These results indicate that both CD200-CD200R1 and CX3CL1-CX3CR1 are involved in the checkpoint mechanisms regulating microglial phenotypes in the early stage of PD and that CD200-CD200R1 signaling is more sensitive. The gene discussed is CX3CL1; the disease is Parkinson disease.